Simplex Trading’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$483K Buy
3,843
+1,443
+60% +$181K ﹤0.01% 619
2025
Q1
$265K Buy
+2,400
New +$265K ﹤0.01% 751
2024
Q4
Hold
0
3485
2024
Q3
Sell
-9,648
Closed -$1.33M 3369
2024
Q2
$1.33M Buy
+9,648
New +$1.33M ﹤0.01% 376
2024
Q1
Hold
0
3436
2023
Q4
Hold
0
3498
2023
Q3
Hold
0
3416
2023
Q2
Hold
0
3462
2023
Q1
Hold
0
3471
2022
Q4
Sell
-3,318
Closed -$352K 3588
2022
Q3
$352K Sell
3,318
-10,785
-76% -$1.14M ﹤0.01% 693
2022
Q2
$1.37M Sell
14,103
-9,456
-40% -$921K ﹤0.01% 282
2022
Q1
$2.21M Buy
+23,559
New +$2.21M ﹤0.01% 275
2021
Q4
Sell
-5,409
Closed -$527K 3816
2021
Q3
$527K Sell
5,409
-800
-13% -$77.9K ﹤0.01% 826
2021
Q2
$604K Buy
+6,209
New +$604K ﹤0.01% 775
2021
Q1
Sell
-1,162
Closed -$111K 3303
2020
Q4
$111K Sell
1,162
-5,529
-83% -$528K ﹤0.01% 1268
2020
Q3
$643K Buy
6,691
+6,690
+669,000% +$643K ﹤0.01% 452
2020
Q2
$0 Buy
+1
New ﹤0.01% 2724
2020
Q1
Hold
0
2736
2019
Q4
Sell
-13,502
Closed -$1.22M 2624
2019
Q3
$1.22M Buy
13,502
+5,176
+62% +$466K ﹤0.01% 184
2019
Q2
$702K Buy
8,326
+1,103
+15% +$93K ﹤0.01% 335
2019
Q1
$636K Buy
+7,223
New +$636K ﹤0.01% 334
2018
Q4
Sell
-6,853
Closed -$842K 2575
2018
Q3
$842K Sell
6,853
-2,216
-24% -$272K ﹤0.01% 327
2018
Q2
$890K Buy
9,069
+8,869
+4,435% +$870K ﹤0.01% 319
2018
Q1
$16K Buy
+200
New +$16K ﹤0.01% 1466
2017
Q4
Sell
-1,076
Closed -$65K 2486
2017
Q3
$65K Buy
1,076
+855
+387% +$51.7K ﹤0.01% 964
2017
Q2
$10K Buy
+221
New +$10K ﹤0.01% 1498
2017
Q1
Sell
-3,618
Closed -$140K 2438
2016
Q4
$140K Buy
+3,618
New +$140K 0.01% 648
2016
Q3
Hold
0
2316
2016
Q2
Sell
-5,408
Closed -$213K 2352
2016
Q1
$213K Buy
+5,408
New +$213K 0.02% 426
2015
Q4
Hold
0
2323
2015
Q3
Sell
-625
Closed -$29K 2362
2015
Q2
$29K Buy
+625
New +$29K ﹤0.01% 1075
2015
Q1
Sell
-10,573
Closed -$236K 2185
2014
Q4
$236K Buy
+10,573
New +$236K 0.03% 279